TABLE 1.
Baseline characteristics
| Baseline characteristics | Steroids/IVIG (N = 41) | Steroids/IVIG/Rituximab (N = 41) |
|---|---|---|
| Mean age at time of transplant ± SD, y | 42 ± 14 | 41 ± 14 |
| Male, n (%) | 24 (58.5) | 27 (66) |
| White, n (%) | 32 (78) | 34 (83) |
| Diabetic ESRD, n (%) | 4 (10) | 8 (19.5) |
| Living donor txp, n (%) | 12 (29) | 12 (29) |
| History of failed allograft, n (%) | 11 (27) | 11 (27) |
| Antithymocyte globulin induction, n (%) | 19 (46) | 21 (51) |
| Alemtuzumab induction, n (%) | 6 (15) | 3 (7) |
| Basiliximab induction, n (%) | 16 (39) | 17 (41) |
| Mean time from transplant to biopsy ± SD, y | 10.5 ± 6.6 | 9.5 ± 8 |
| Mean follow-up from transplant ± SD, y | 12.5 ± 6.5 | 12 ± 8 |
| Mean follow-up from biopsy ± SD, y | 2 ± 1 | 3 ± 1 |
| Time between two biopsies ± SD, mo | 5 ± 4.6 | 4 ± 2 |
ESRD, End-Stage Renal Disease; txp, transplantation.